Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) Study
Metabolic syndrome (MetS) has been shown to be associated with an increased risk of gastric cancer. However, the impact of MetS on gastric cancer mortality remains largely unknown. Here, we prospectively examined the prediction of preoperative MetS for gastric cancer mortality by analyzing a subset...
Main Authors: | Dan Hu, Feng Peng, Xiandong Lin, Gang Chen, Hejun Zhang, Binying Liang, Kaida Ji, Jinxiu Lin, Lin-Feng Chen, Xiongwei Zheng, Wenquan Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396416305837 |
Similar Items
-
Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study
by: Dan Hu, et al.
Published: (2018-08-01) -
Analysis of Preoperative Metabolic Risk Factors Affecting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma: The Fujian Prospective Investigation of Cancer (FIESTA) Study
by: Feng Peng, et al.
Published: (2017-02-01) -
Prediction of presurgical metabolic syndrome for gastric cancer‐specific mortality is more evident in smokers: The FIESTA study
by: Xinran Zhang, et al.
Published: (2023-02-01) -
Prognostic value of long-term antidiabetic and antihypertensive therapy in postoperative gastric cancer patients: the FIESTA study
by: Laicheng Wang, et al.
Published: (2022-10-01) -
Prognostic Value of an Inflammation-Related Index in 6,865 Chinese Patients With Postoperative Digestive Tract Cancers: The FIESTA Study
by: Xinran Zhang, et al.
Published: (2019-05-01)